AlphaMaven AlphaMaven

Ares Management Corp Stock Baskets | BSP:A2RE34

Reported by gurufocus
Apr 11, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Ares Management (ARES on NYSE; A2RE34 on B3/São Paulo) traded at $100.46 on April 10, 2026, down 4.14% that day and approaching its 52-week low of $95.80, reflecting broad sell-off pressure on the alternative asset manager.
  • • Brazilian-listed shares (A2RE34:SAO) closed at R$54.90, representing 9.80% above their March 13, 2026 52-week low of R$50.00, while the same security on B3 (BSP:A2RE34) traded at R$53.25 with a market cap of R$11.95 billion ($2.39 billion USD equivalent).
  • • Valuation metrics show significant disconnect: A2RE34 trades at 44.7% discount to estimated GF Value of R$96.30, signaling potential undervaluation or market-driven repricing of the alternative asset manager's cash flow generation from fees.
  • • Negative pressure stems from broader private lending market concerns, including risk signals from major banks like JPMorgan that eroded investor confidence in companies with direct lending and private credit exposure.
  • • Ares Management operates three core segments—Direct Lending Group, Private Equity Group, and Real Estate Group—targeting investments between $1 million and $500 million in companies with $10 million to $250 million EBITDA, positioning it as a significant player in alternative assets across North America, Europe, and Asia-Pacific.
Summary
Ares Management Corporation, a Los Angeles-headquartered alternative asset manager founded in 1997, faced significant headwinds as of April 10, 2026. The company's NYSE-listed shares (ARES) declined 4.14% to close at $100.46, approaching the 52-week low of $95.80 established earlier in the year. Concurrently, Ares' Brazilian depository receipts (A2RE34:SAO and BSP:A2RE34) traded at approximately R$53.25–R$54.90, reflecting consistent pressure across multiple listings.

The sell-off reflects a confluence of market dynamics affecting the alternative lending and private credit sectors. According to available market intelligence, Ares' share decline accelerated alongside broader concerns about risks in the private lending market, particularly following risk signals from major financial institutions including JPMorgan. These signals prompted a wider loss of investor confidence in companies with material exposure to direct lending assets. For Ares Management, whose Direct Lending Group represents a significant operational segment, this repricing has proven consequential.

Valuation metrics underscore the disconnect between market price and intrinsic value estimates. The Brazilian-listed A2RE34 security trades at a 44.7% discount to its GF Value estimate of R$96.30, suggesting either substantial undervaluation or market-driven reassessment of the firm's fee-generating cash flows. The company's trailing price-to-earnings multiple stands at 6.11x on trailing twelve-month earnings per share of R$8.72, positioning it at relatively compressed valuations despite operational diversification across direct lending, private equity (middle market, growth, mezzanine, and distressed buyouts), and real estate investment segments. Ares maintains institutional shareholder support, with major holders including Vanguard, BlackRock, Capital World Investors, and State Street, though recent volatility may prompt portfolio rebalancing among some positions.

The company's operational footprint spans North America, Europe, Asia-Pacific, Southeast Asia, and Australia, with investment targets typically ranging from $1 million to $500 million across portfolio companies generating $10 million to $250 million in EBITDA. Ares also pays quarterly dividends to shareholders—most recently $1.35 per share as of the March 31, 2026 ex-dividend date of March 17, 2026—providing income support amid equity price weakness. With approximately 3,967 full-time employees and a 5-year monthly beta of 1.54, Ares exhibits volatility amplified relative to the broader S&P 500.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial